排序方式: 共有39条查询结果,搜索用时 156 毫秒
1.
近年来,人们运用诊断技术,特别是分子生物学技术诊断肝脏疾病。现就一些新的核酸检测技术、肝活检技术和血清标记物的临床应用做一总结。 相似文献
2.
4.
5.
目的:两种不同方法评估替比夫定治疗慢性乙型肝炎患者肾小球滤过率的变化。方法回顾性分析2009年9月至2012年9月在复旦大学附属华山医院单用替比夫定600 mg/d 口服治疗的慢性乙型肝炎患者资料。比较基于血清肌酐(Cr)及血清胱抑素 C 计算的肾小球滤过率。统计学处理采用t检验及秩和检验。结果患者共45例,男31例,女14例。患者 Cr 水平在抗病毒治疗前、治疗52周和104周三个时间点分别为(67.00±12.27)、(62.56±10.85)、(61.68±13.31)μmol/L,差异无统计学意义。患者血清胱抑素 C 水平在抗病毒治疗前、治疗52周和104周三个时间点分别为(0.8434±0.1113)、(0.7927±0.1204)、(0.7715±0.0915)mg/L。患者血清胱抑素 C 水平在抗病毒治疗52周和104周均较治疗前下降,差异有统计学意义(t=2.063,P=0.0421和t=3.053,P=0.0031)。基于血清肌酐计算的肾小球滤过率在抗病毒治疗前、治疗52周和104周三个时间点中位数分别为123.6、123.8、123.7 mL/min/1.73 m2,差异无统计学意义。基于血清胱抑素 C 计算的肾小球滤过率在抗病毒治疗前、52周和104周三个时间点分别为 (107.3±15.8)、(113.6±18.7)、(115.1±13.8)mL/min/1.73 m2,基于血清胱抑素 C 计算的肾小球滤过率在104周较治疗前升高,差异有统计学意义(t=2.284,P=0.0252)。结论在使用替比夫定治疗慢性乙型肝炎的患者中,肾小球滤过率有改善,基于血清胱抑素 C 计算的肾小球滤过率较基于血清肌酐计算的肾小球滤过率更加敏感。 相似文献
6.
目的 研究HBV干预后小鼠肝脏树突状细胞P-干扰素调节因子3及其下游Ⅰ型干扰素表达的变化.方法用免疫磁珠分选法分离肝脏树突状细胞,并用粒细胞-巨噬细胞集落刺激因子和白细胞介素4在24孔板中诱导培养.用超离心技术获得HBV,并用实时荧光定量PCR检测.第5天将培养的树突状细胞分为2组:HBV组与HBV共同培养,对照组加入等量的细胞培养液.24 h后,两组均加入聚肌胞刺激,收集0、1、2、6、24 h的细胞和上清液,用Western blot检测P-干扰素调节因子3的表达情况,用酶联免疫吸附法检测上清液中干扰素β的浓度.组间比较用t检验.结果 0h时HBV组培养液上清液干扰素β浓度[(12.38 ±3.71)pg/ml]与对照组[(10.83±4.11)pg/ml]比较,差异无统计学意义(P>0.05).聚肌胞刺激后6 h,HBV组培养液上清液干扰素β浓度[(88.67±9.01)pg/ml]与对照组[(137.68±12.28)pg/ml]比较,t=9.653,P<0.01,差异有统计学意义.聚肌胞刺激后24h,HBV组培养液上清液干扰素β浓度[(69.89±5.80)pg/ml]与对照组[(72.25±8.61)pg/ml]比较,差异无统计学意义(P>0.05).聚肌胞刺激小鼠肝脏树突状细胞后P-干扰素调节因子3表达逐渐增强.经HBV干预在感染时病毒与细胞数量的比值为25,24 h后再用聚肌胞刺激2 h,HBV组P-干扰素调节因子3表达较对照组减弱.结论 HBV干预后小鼠肝脏树突状细胞P-干扰素调节因子3及其下游Ⅰ型干扰素表达均下调.Abstract: Objective To detect the secretions of type Ⅰ interferon and the expressions of phospho-IRF3 in murine liver dendritic cells intervened by HBV.Methods The murine liver dendritic cells were isolated via anti-CD11c microbeads and were incubated in the presence of GM-CSF and IL-4 to induce the DC generation and proliferation in 24-well cell culture plates.HBV virions were isolated via ultracentrifugation and were detected by quantitative Realtime-PCR.The DCs were divided into two groups:one group was cultured with HBV virions for 24 hours,the other group was cultured without HBV as control group.The cells were harvested at Oh,1h,2h,6h and 24h after being stimulated with poly I:C and the expressions of pIRF3 and the concentration of IFN β in supematants were detected with western blot and ELISA respectively.Results The IFN β concentrations at 0h,6h and 24h in the supernatants of the RBV group and the control group were(12.38±3.71)pg/ml,(88.67±9.01)pg/ml and(69.89±5.80)pg/ml vs(10.83±4.11)pg/ml,(137.68 ± 12.28) pg/ml and (72.25 ± 8.61) pg/ml,respectively. No statistical differences found at 0 h (t =0.8398,P > 0.05) and 24 h (t = 0.6820,P > 0.05) between the two groups except that at 6 h (t = 9.653,P <0.01). The expressions of phospho-IRF3 in HBV group were lower than that in control group. Conclusions The type Ⅰ interferon secretion and the phospho-IRF3 expression were decreased in murine liver dendritic cells when intervened by HBV. 相似文献
7.
抗乙型肝炎病毒药物的合理应用 总被引:1,自引:0,他引:1
世界上有3.5亿人为慢性乙型肝炎病毒(HBV)感染者[1],其中约有15%~40%病人会进展为肝硬化、肝功能失代偿以及肝细胞癌[2]。近10多年来,抗HBV药物的研究也有了很大的进展,涌现出很多新药。 相似文献
8.
戊型病毒性肝炎(简称戊型肝炎)在临床表现和实验室生化检查方面与其他病毒性肝炎差别不大,诊断主要依靠实验室病原学检查。传统观念认为,戊型肝炎为自限性疾病,如果患者为慢性肝炎可不考虑是戊型肝炎病毒(HEV)感染。但已有研究发现, 相似文献
9.
10.